Filing Flows › Regen BioPharma (RGBP) › Q2 FY26 › vs Q2 FY25
Regen BioPharma (RGBP) Q2 FY26 vs Q2 FY25 (year over year)
Regen BioPharma's revenue rose $0 (0%) from $59K in Q2 FY25 to $59K in Q2 FY26.
Regen BioPharma, Q2 FY26: revenue $59K (0% year over year), operating margin -260.2%, net earnings $992K, operating cash flow −$63K. The chart draws each line against Q2 FY25, the increases inside each band.
Every line
| Line | Q2 FY26 | Q2 FY25 | Change | % |
|---|---|---|---|---|
| Revenue | $59K | $59K | $0 | 0% |
| Other income, net | $1.1M | $94K | $1.1M | 12× |
| Costs & expenses | $1.2M | $172K | $1.0M | +599% |
| Operating costs | $213K | $172K | $40K | +23% |
| Net earnings | $992K | −$19K | $1.0M | — |
| General & admin | $32K | $13K | $19K | +141% |
| Other operating costs | $178K | $159K | $19K | +12% |
| Operating cash sources | $1.1M | $82K | $973K | 13× |
| Cash used in operations | $63K | $101K | −$38K | -38% |
| Working capital & other | $1.1M | $82K | $973K | 13× |
Questions
How much did Regen BioPharma's revenue grow year over year in Q2 FY26?
Regen BioPharma's revenue rose $0 (0%) from $59K in Q2 FY25 to $59K in Q2 FY26.